On April 6, 2021, Aura Biosciences, Inc. closed the transaction. The company has received $483,829 in its second and final tranche. The transaction included participation from 41 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.49 USD | -2.73% | +1.22% | -15.46% |
04-15 | Raj Parekh to Resign as Member of the Board of Directors of Aura Biosciences, Inc., Effective June 20, 2024 | CI |
03-27 | Aura Biosciences Shares Rise Following Q4 Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.46% | 381M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it has received $80.483829 million in funding from a group of investors